Nadia A. Lanman
Impact in
- Cancer Research top 10%
- Immunology top 10%
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- Epigenetics and DNA Methylation 5
-
- Prostate Cancer Treatment and Research 6
- Co-authors
- Jo Ann Banks (5 shared papers)Sandro Matosevic (6 shared papers)Sagar M. Utturkar (15 shared papers)Jiao Wang (4 shared papers)Xiaoqi Liu (5 shared papers)Lijun Cheng (3 shared papers)Kyle B. Lupo (4 shared papers)Elia Farah (4 shared papers)
- Journals
- Cancer Research (6 papers)Frontiers in Immunology (4 papers)Oncogene (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)Scientific Reports (3 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Nadia A. Lanman
57 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 100
- Cancer Research 194
- Immunology 262
- Oncology 305
- Physiology 40
- Molecular Biology 536
Countries citing papers authored by Nadia A. Lanman
This map shows the geographic impact of Nadia A. Lanman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia A. Lanman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia A. Lanman more than expected).
Fields of papers citing papers by Nadia A. Lanman
This network shows the impact of papers produced by Nadia A. Lanman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia A. Lanman. The network helps show where Nadia A. Lanman may publish in the future.
Co-authors
The 25 scholars most cited alongside Nadia A. Lanman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 132 | |
| 2 | 2018 | 99 | |
| 3 | 2016 | 82 | |
| 4 | 2021 | 69 | |
| 5 | 2019 | 66 | |
| 6 | 2019 | 61 | |
| 7 | 2019 | 51 | |
| 8 | 2020 | 48 | |
| 9 | 2019 | 47 | |
| 10 | 2022 | 43 | |
| 11 | 2023 | 42 | |
| 12 | 2020 | 39 | |
| 13 | 2015 | 38 | |
| 14 | 2017 | 37 | |
| 15 | 2022 | 34 | |
| 16 | 2024 | 32 | |
| 17 | 2017 | 32 | |
| 18 | 2020 | 31 | |
| 19 | 2023 | 27 | |
| 20 | 2017 | 25 |
About Nadia A. Lanman
Nadia A. Lanman is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Immunology, having authored 62 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (7 papers), Prostate Cancer Treatment and Research (6 papers), MicroRNA in disease regulation (6 papers), Epigenetics and DNA Methylation (5 papers), Antifungal resistance and susceptibility (5 papers), Immune cells in cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Cancer Research (194 citations), Immunology (262 citations), Oncology (305 citations), Physiology (40 citations) and Molecular Biology (536 citations). Nadia A. Lanman has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Jo Ann Banks, Sandro Matosevic, Sagar M. Utturkar, Jiao Wang, Xiaoqi Liu, Lijun Cheng, Kyle B. Lupo, Elia Farah, Pete E. Pascuzzi and Andrea M. Chambers. Their work appears in journals such as Cancer Research, Frontiers in Immunology, Oncogene, Antimicrobial Agents and Chemotherapy and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.